Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial.

Trial Profile

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Depression; Mental disorders; Mood disorders; Traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2011 Planned end date changed from 1 Apr 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 08 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Nov 2010 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top